Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maju Mathew Koola

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
The Primary Care Companion for CNS Disorders|March 24, 2018
Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target EngagementMaju Mathew Koola
Schizophrenia Research|November 27, 2018
Can N‑acetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?Maju Mathew Koola
Indian Journal of Psychological Medicine|April 27, 2016
Cytokines in Schizophrenia: Hope or Hype?Maju Mathew Koola
Indian Journal of Psychological Medicine|March 25, 2016
Methodological Issues in Cytokine Measurement in SchizophreniaMaju Mathew Koola
Schizophrenia Research. Cognition|April 13, 2016
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineMaju Mathew Koola
Molecular Neuropsychiatry|November 7, 2018
Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?Maju Mathew Koola
Asian Journal of Psychiatry|February 19, 2019
Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophreniaMaju Mathew Koola
Asian Journal of Psychiatry|November 19, 2017
Galantamine and memantine combination for cognition: Enough or more than enough to translate from murines and macaques to men with schizophrenia?Maju Mathew Koola
Human Psychopharmacology|September 23, 2020
Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyondMaju Mathew Koola
Molecular Neuropsychiatry|January 16, 2019
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of SchizophreniaMaju Mathew Koola
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The Primary Care Companion for CNS Disorders|March 24, 2018
Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target EngagementMaju Mathew Koola
Schizophrenia Research|November 27, 2018
Can N‑acetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?Maju Mathew Koola
Indian Journal of Psychological Medicine|April 27, 2016
Cytokines in Schizophrenia: Hope or Hype?Maju Mathew Koola
Indian Journal of Psychological Medicine|March 25, 2016
Methodological Issues in Cytokine Measurement in SchizophreniaMaju Mathew Koola
Schizophrenia Research. Cognition|April 13, 2016
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineMaju Mathew Koola
Molecular Neuropsychiatry|November 7, 2018
Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?Maju Mathew Koola
Asian Journal of Psychiatry|February 19, 2019
Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophreniaMaju Mathew Koola
Asian Journal of Psychiatry|November 19, 2017
Galantamine and memantine combination for cognition: Enough or more than enough to translate from murines and macaques to men with schizophrenia?Maju Mathew Koola
Human Psychopharmacology|September 23, 2020
Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyondMaju Mathew Koola
Molecular Neuropsychiatry|January 16, 2019
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of SchizophreniaMaju Mathew Koola
Pageof 8